Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
40.64
-2.46 (-5.71%)
Mar 13, 2025, 4:00 PM EST - Market closed
Guardant Health Revenue
In the year 2024, Guardant Health had annual revenue of $739.02M with 31.04% growth. Guardant Health had revenue of $201.81M in the quarter ending December 31, 2024, with 30.16% growth.
Revenue (ttm)
$739.02M
Revenue Growth
+31.04%
P/S Ratio
6.75
Revenue / Employee
$365,668
Employees
2,021
Market Cap
5.02B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
GH News
- 1 day ago - Guardant Health: Great Buy On Dips For Strong Diagnostics Verticals Despite Premium Valuation - Seeking Alpha
- 2 days ago - Medicare To Reimburse Guardant Health's Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue - Benzinga
- 3 days ago - Guardant Health Receives ADLT Status From CMS for Shield Blood Test - Business Wire
- 13 days ago - Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 15 days ago - New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change - Business Wire
- 20 days ago - What's Going On With Cancer Diagnostic Firm Guardant Health On Friday? - Benzinga
- 21 days ago - Guardant Health, Inc. (GH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook - Business Wire